Product correctly added to cart.

discount label
Repaglinide
View 3D

Biosynth logo

Repaglinide

CAS: 135062-02-1

Ref. 3D-FR27699

1g
136.00 €
2g
192.00 €
5g
271.00 €
10g
406.00 €
25g
588.00 €
Estimated delivery in United States, on Thursday 16 Jan 2025

Product Information

Name:
Repaglinide
Synonyms:
  • (S)-2-Ethoxy-4-[2-[[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic acidAG-EE-623Novonorm
  • (S)-(+)-2-Ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methylbutyl]amino]carbonyl]methyl]benzoic acid
  • (S)-(+)-Repaglinide
  • (S)-2-Ethoxy-4-[2-[[3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid
  • 2-Ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid
  • Ag-Ee 623Zw
  • Agee 623
  • Benzoic acid, 2-ethoxy-4-[2-[[3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-, (S)-
  • Enyglid
  • Eurepa
  • See more synonyms
  • Europa 0.5
  • Europa 1
  • GlucoNorm
  • NovoNorm
  • Novolon
  • Prandin
  • Benzoic acid, 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-
Description:

ATP-sensitive K+Â channel inhibitor; anti-diabetic drug

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
452.59 g/mol
Formula:
C27H36N2O4
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FR27699 Repaglinide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".